Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...
Opportunities in the pain market include developing NaV inhibitors like NaV1.8 and NaV1.7, diversifying pain therapeutics by molecule type, and capitalizing on the fast-growing nociceptive pain sector ...
TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and oligonucleotide capabilities, unifying therapeutic design across all major ...
Scientists working in emerging modalities leverage robust quality systems & advanced analytical methods for development, clinical, and commercial success.
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more ...